How Deep Should You Squat? Mobility Limits vs. Your Anatomy
Find your controllable squat depth, tell trainable mobility from hip anatomy, and see what deep-squat research does and does not show.
The latest health, wellness & fitness journalism from the publications of the VUGA Enterprises Network — refreshed around the clock. Every headline opens the full story at its source.
Page 6 of 6 · Updated 9 Oct 2026, 18:23 UTC
Find your controllable squat depth, tell trainable mobility from hip anatomy, and see what deep-squat research does and does not show.
The DEA moved to temporarily schedule kratom-derived 7-OH on July 1, 2026, per the agency. What the crackdown means for wellness drinks and supplement.
A NUTRITION 2026 study found no sodium reduction in packaged foods since FDA's 2021 voluntary goals. How to cut sodium from your own cart.
00 EPS. What the insurer's recovery quarter signals for 2027 plan……
Mammogram guidelines compared: USPSTF 2024 says every two years from 40, ACS from 45 — tradeoffs, dense breasts, high-risk schedules, and next steps.
Why trials measure stand-ins instead of outcomes you feel, when surrogates fail — CAST, torcetrapib — and how to spot the trick.
Home workouts with no equipment that work: a 20-minute five-move bodyweight circuit, progression rules, and research showing it rivals gym training.
How hospital charity care works under IRS 501(r): eligibility, the 120-day collections rule, a step-by-step application, and the traps that cost patients.
A 2019 BMJ meta-analysis found no weight benefit and ~260 extra calories a day. Where the breakfast myth came from and who genuinely benefits.
What health insurers can and cannot price on after the ACA: five rating factors, where medical underwriting persists, and SEP windows.
What causes dandruff? Malassezia yeast, not dry skin. Evidence-backed shampoos — zinc pyrithione, ketoconazole — and when to see a dermatologist.
What melatonin actually does: circadian timing yes, general insomnia no per AASM. Dose ranges, gummy mislabeling findings, and safety for children and…
The FTC finalized a $4 million order against TruHeight on July 15, 2026 over kids' height-growth claims and fake reviews. What parents should know.
FDA approved Lipfendra (enlicitide) on July 15, 2026 — the first oral PCSK9 inhibitor. How it compares with injectables and what coverage will decide.
The FDA's June 2026 meeting advanced its Food Traceability Rule. How supply-chain tracking records will make food recalls faster and narrower.
The VUGA Enterprises Newsroom aggregates headlines and short excerpts from the newspapers and magazines of the VUGA Enterprises Network. Every headline links to the full story on the publishing site. Part of the VUGA Network.